BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Titov A, Kaminskiy Y, Ganeeva I, Zmievskaya E, Valiullina A, Rakhmatullina A, Petukhov A, Miftakhova R, Rizvanov A, Bulatov E. Knowns and Unknowns about CAR-T Cell Dysfunction. Cancers (Basel) 2022;14:1078. [PMID: 35205827 DOI: 10.3390/cancers14041078] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Ren A, Tong X, Xu N, Zhang T, Zhou F, Zhu H. CAR T-Cell Immunotherapy Treating T-ALL: Challenges and Opportunities. Vaccines (Basel) 2023;11. [PMID: 36680011 DOI: 10.3390/vaccines11010165] [Reference Citation Analysis]
2 Sakai T, Lin W. Kupffer Cells as a Target for Immunotherapy. J 2022;5:532-537. [DOI: 10.3390/j5040036] [Reference Citation Analysis]
3 Chocarro L, Blanco E, Fernández-Rubio L, Arasanz H, Bocanegra A, Echaide M, Garnica M, Ramos P, Piñeiro-Hermida S, Vera R, Kochan G, Escors D. Cutting-Edge CAR Engineering: Beyond T Cells. Biomedicines 2022;10. [PMID: 36551788 DOI: 10.3390/biomedicines10123035] [Reference Citation Analysis]
4 Harrer DC, Schenkel C, Berking C, Herr W, Abken H, Dörrie J, Schaft N. Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells. Cancers (Basel) 2022;14:5033. [PMID: 36291817 DOI: 10.3390/cancers14205033] [Reference Citation Analysis]
5 Pinard CJ, Lagree A, Lu F, Klein J, Oblak ML, Salgado R, Cardenas JCP, Brunetti B, Muscatello LV, Sarli G, Foschini MP, Hardas A, Castillo SP, Abduljabbar K, Yuan Y, Moore DA, Tran WT. Comparative Evaluation of Tumor-Infiltrating Lymphocytes in Companion Animals: Immuno-Oncology as a Relevant Translational Model for Cancer Therapy. Cancers 2022;14:5008. [DOI: 10.3390/cancers14205008] [Reference Citation Analysis]
6 Reyna RA, Maruyama J, Mantlo EK, Manning JT, Taniguchi S, Makishima T, Lukashevich IS, Paessler S. Depletion of CD4 and CD8 T Cells Reduces Acute Disease and Is Not Associated with Hearing Loss in ML29-Infected STAT1-/- Mice. Biomedicines 2022;10:2433. [DOI: 10.3390/biomedicines10102433] [Reference Citation Analysis]
7 Hirobe S, Nagai S, Tachibana M, Okada N. Binding and Efficacy of Anti-Robo4 CAR-T Cells against Solid Tumors. Biomedicines 2022;10:1273. [DOI: 10.3390/biomedicines10061273] [Reference Citation Analysis]